AMPLY was founded by an experienced founding management team, including the CEO Dr Ben Thomas and CTO Dermot Tierney. Ben moved to biology as a mature student, completing a PhD in computational biology at Aberystwyth University in 2018, before following on that work at Queen’s University, Belfast as a PDRA. It was here he met Dermot and both decided the potential present in the AI platform warranted pursuing a commercial avenue to realise the immense potential of the AMPLYfolio system. Augmented by non-executive advisors with deep domain knowledge and a strong technical and commercial skillsets the team has also been enhanced by two skilled microbiologists in Dr Jurnorain Gani and Peter Alexander.
AMPLY Discovery now has a combined 100 years experience in biotech, computational biology, animal and human health, and technology licensing.
Dr Ben Thomas (CEO/CTO)
20+ years experience in dairy farming, financial asset management, predictive marketing, computational biology and software design
Dermot Tierney (CFO)
20+ years industry experience, technology licensing and business development
Dr Jurnorain Gani
Synthetic drug synthesis and performance specialist with extensive hospital-based clinical background
Dr Peter Alexander
Specialist in antimicrobial drug discovery and development, biochemistry and microbiology
Prof. Chris Creevey
Computational biologist with an interest in applying ecological and evolutionary principals to microbial communities
Prof. Sharon Huws
Sharon’s key research is strategically focused on understanding the functionality of rumen microbes—with the aim of addressing food security and human health.